Abciximab

From Ganfyd

Jump to: navigation, search
rINN: Abciximab
Other Names
Erbitux®
Pharmacological Information
Web information on Abciximab
NHS Evidence on Abciximab
DrugBank on Abciximab
Mechanism of Action
Monoclonal antibody that binds to glycoprotein IIb/IIIa receptors and related sites on platelets
Other Issues for Abciximab
Use once only to avoid risk thrombocytopenia
Relevant Clinical Literature
Pubmed on Abciximab
RCT with Abciximab
Systematic reviews of Abciximab
Abciximab in N Eng J Med, Lancet, JAMA, BMJ
Abciximab in Cochrane Collaboration
TRIP Database on Abciximab
Google Scholar on Abciximab
Bandolier on Abciximab
UK Guidance
Nice Guidance on Abciximab

BNF-registration required
BNF for children-registration required

UK directory of medicines
UK Medicine Guide (eg pictures of capsules)
Centre for Reviews and Dissemination databases -DARE & NHS EED (evaluates reliability of research)
Prodigy Guidance on Abciximab
Regulatory Literature
UK SPCs of medicines with marketing authorisation
EMEA search
FDA search
Other Literature
PubChem on Abciximab
CTD (Comparative Toxicogenomics Database) link
ChemIndustry.com link
Protein Structural Information
Biological Information (GenomeNet)
Protein Knowledgebase (UniProtKB)
Please read pharmacological data limitations
Other Wikis
Medpedia on Abciximab (Less technical, good quality control)
Wikipedia on Abciximab (Less technical, ? quality control)
Abciximab is a glycoprotein IIb/IIIa inhibitor in development. When combined with heparin in the treatment of NSTEMI proceeding to percutaneous coronary intervention the combination is inferior to bivalirudin.
Retrieved from "http://www.ganfyd.org/index.php?title=Abciximab"
Personal tools